Seytu Spot

Description

SEYTÚ® SYSTEM SPOT-SPECIALIST Spot Gel is a localized gel formulation designed for the treatment of acne. Each 0.5 fl oz (15 mL) tube contains 2% salicylic acid, a well-known active ingredient for acne management. The formulation is enhanced with postbiotics and madecassoside, contributing to its efficacy and skin-soothing properties. This product is manufactured in the USA using globally sourced ingredients and is classified as hypoallergenic. It has not been tested on animals. The product is imported and/or distributed by Omnilife USA, Inc., located at 3900 South Freeway, Fort Worth, TX 76110.

Uses and Indications

This drug is indicated for the treatment of acne. It is specifically designed to reduce the severity of new acne pimples, blackheads, and whiteheads.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer. This can be done one to three times daily, depending on the patient's needs and the physician's guidance.

It is advisable to initiate treatment with one application per day to minimize the risk of excessive skin drying. Based on the patient's response, the frequency may be gradually increased to two or three times daily as necessary or as directed by a healthcare provider.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to once a day or every other day to alleviate these symptoms.

Contraindications

There are no contraindications listed for this product. However, it is essential to adhere to the recommended applications, as exceeding these may lead to adverse effects.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to discontinue use and consult a physician if they experience skin irritation or prolonged stinging.

The likelihood of skin irritation and dryness increases when this product is used concurrently with other topical acne medications. Therefore, it is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a poison control center without delay. Additionally, patients should be cautioned to avoid contact with the eyes. Should contact occur, it is imperative to flush the eyes thoroughly with water.

Side Effects

Patients using this product may experience adverse reactions, which can vary in severity. Serious warnings include the necessity for external use only. In the event of skin irritation or prolonged stinging, patients are advised to discontinue use and consult their physician.

Common adverse reactions include skin irritation and dryness, particularly when used concurrently with other topical acne medications. It is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

In cases of accidental ingestion, patients should seek medical assistance or contact a poison control center immediately. Additionally, care should be taken to avoid contact with the eyes; if contact occurs, it is essential to flush the eyes thoroughly with water.

Drug Interactions

Skin irritation and dryness may be exacerbated when using another topical acne medication concurrently. To minimize the risk of irritation, it is advised to use only one topical acne medication at a time.

No specific drug or laboratory test interactions have been identified in the available data.

Packaging & NDC

Below are the non-prescription pack sizes of Seytu Spot (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this product. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a poison control center is advised.

Care should be taken to avoid contact with the eyes; if contact occurs, the affected area should be flushed thoroughly with water. Due to the potential for excessive drying of the skin, it is recommended to initiate treatment with one application daily. The frequency may be gradually increased to two or three times daily as needed or directed by a healthcare professional.

If patients experience bothersome dryness or peeling, the application frequency should be reduced to once a day or every other day.

Geriatric Use

There is no specific information regarding the use of SEYTU SPOT (salicylic acid gel) in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects is advisable in this population, given the lack of established guidelines for geriatric use.

Pregnancy

The safety of salicylic acid during pregnancy has not been established, and its use is contraindicated due to potential risks to the fetus. There may be a risk of teratogenic effects associated with the use of salicylic acid during pregnancy. Therefore, pregnant women should avoid using this product unless directed by a healthcare provider. It is recommended that women who are pregnant or planning to become pregnant consult a physician before using this product to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of SEYTÚ Spot Gel in lactating mothers. Additionally, there is no information available about the potential for excretion of SEYTÚ Spot Gel in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is essential. If the substance is ingested, healthcare professionals should be contacted without delay, or the individual should reach out to a poison control center for guidance.

It is crucial to avoid any contact with the eyes. Should contact occur, the affected area must be flushed thoroughly with water to mitigate potential irritation or damage.

Prompt action and adherence to these recommendations are vital in managing overdosage situations effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a poison control center if the medication is swallowed. It is important to emphasize the need to avoid contact with the eyes; in the event of contact, patients should flush the eyes thoroughly with water.

Patients should be informed that using this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness. Therefore, if irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time.

Providers should instruct patients to adhere strictly to the usage instructions provided on the label. Additionally, it is crucial to communicate that patients should not exceed the recommended number of applications to ensure safety and efficacy.

Storage and Handling

The product is supplied in packaging that includes a security seal. It is imperative that the product not be used if the security seal has been broken, as this may indicate potential tampering or contamination.

For optimal storage, the product should be kept in a controlled environment, away from direct sunlight and moisture. Specific temperature ranges for storage are not provided; however, it is advisable to maintain a stable, cool environment to ensure product integrity.

Special handling precautions should be observed to prevent damage to the packaging and to maintain the security seal intact.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Seytu Spot, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)